Roger Louis

Acting Head Research & Development at Novelion Therapeutics - , ,

Roger Louis's Contact Details
HQ
N/A
Location
Needham, Massachusetts
Company
Novelion Therapeutics
Roger Louis's Company Details
Novelion Therapeutics logo, Novelion Therapeutics contact details

Novelion Therapeutics

, , • 250 - 499 Employees
Other

Novelion Therapeutics is a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare diseases. Novelion has a diversified commercial portfolio through its indirect subsidiary, Aegerion Pharmaceuticals, Inc. (Aegerion), which includes MYALEPT® and JUXTAPID®, and is also developing zuretinol acetate for the potential treatment of inherited retinal disease caused by underlying mutations in RPE65 or LRAT genes. The company seeks to advance its portfolio of rare disease therapies by investing in science and clinical development.

N/A
Details about Novelion Therapeutics
Frequently Asked Questions about Roger Louis
Roger Louis currently works for Novelion Therapeutics.
Roger Louis's role at Novelion Therapeutics is Acting Head Research & Development.
Roger Louis's email address is ***@novelion.com. To view Roger Louis's full email address, please signup to ConnectPlex.
Roger Louis works in the Other industry.
Roger Louis's colleagues at Novelion Therapeutics are Weger, Mary, Mary Weger, Eileen Rogers, Michael Colacino, Craig Quinn, Iris Cheong, Susan Devlin and others.
Roger Louis's phone number is N/A
See more information about Roger Louis